Moderna, Inc., United States
Disclosure information not submitted.
Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy: An Observational Database Study
Monday, August 26, 20242:45 PM – 3:00 PM CEST
Estimating the risk of transient ischemic attacks and non-hemorrhagic stroke following Spikevax bivalent compared to influenza vaccination in the US
Wednesday, August 28, 20242:30 PM – 2:45 PM CEST
